Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.49% |
| 2 | Energy | 5.29% |
| 3 | Technology | 4.48% |
| 4 | Financials | 3.44% |
| 5 | Consumer Discretionary | 3.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTR
5176
PUT
DELISTED
Frontier Communications Corp.
FTR
| $102K | ﹤0.01% |
1,133
-6,454
| -85% | -$615K |
|
5177
CALL
Crane NXT
CXT
$2.97B
| $101K | ﹤0.01% |
4,606
+4,030
| +700% | +$97.7K |
|
5178
DexCom
DXCM
$34.2B
| $101K | ﹤0.01% |
10,372
+2,084
| +25% | +$21.3K |
|
|
EMBJ
5179
CALL
Embraer S.A. ADS
EMBJ
$13.4B
| $101K | ﹤0.01% |
2,600
-900
| -26% | -$34.9K |
|
5180
CALL
Imunon
IMNN
$6.98M
| $101K | ﹤0.01% |
18
+2
| +13% | +$17.4K |
|
5181
Mesa Laboratories
MLAB
$614M
| $101K | ﹤0.01% |
1,733
-157
| -8% | -$11.4K |
|
5182
Saic
SAIC
$5.35B
| $101K | ﹤0.01% |
2,308
-2,892
| -56% | -$127K |
|
5183
SS&C Technologies
SSNC
$19B
| $101K | ﹤0.01% |
4,726
+1,206
| +34% | +$26.7K |
|
5184
CALL
iShares TIPS Bond ETF
TIP
$14.7B
| $101K | ﹤0.01% |
900
-1,200
| -57% | -$137K |
|
|
CMRX
5185
DELISTED
Chimerix, Inc.
CMRX
| $101K | ﹤0.01% |
3,728
-5,181
| -58% | -$126K |
|
|
GHDX
5186
DELISTED
Genomic Health, Inc.
GHDX
| $101K | ﹤0.01% |
3,575
-3,334
| -48% | -$93K |
|
|
UN
5187
CALL
DELISTED
Unilever NV New York Registry Shares
UN
| $101K | ﹤0.01% |
2,600
+900
| +53% | +$37.5K |
|
|
AMED
5188
PUT
DELISTED
Amedisys
AMED
| $100K | ﹤0.01% |
5,000
-2,900
| -37% | -$56K |
|
5189
BioCryst Pharmaceuticals
BCRX
$2.44B
| $100K | ﹤0.01% |
11,108
-4,147
| -27% | -$50.8K |
|
5190
Buckle
BKE
$2.27B
| $100K | ﹤0.01% |
2,216
-1,613
| -42% | -$74.5K |
|
5191
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$148M
| $100K | ﹤0.01% |
4,500
| – | – |
|
5192
Graham Corp
GHM
$1.3B
| $100K | ﹤0.01% |
3,546
+762
| +27% | +$23.7K |
|
5193
CALL
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.32B
| $100K | ﹤0.01% |
833
-434
| -34% | -$53.4K |
|
5194
Nelnet
NNI
$4.55B
| $100K | ﹤0.01% |
2,349
-5,654
| -71% | -$243K |
|
|
TYG
5195
Tortoise Energy Infrastructure Corp
TYG
$1.13B
| $100K | ﹤0.01% |
526
-150
| -22% | -$28.7K |
|
5196
Tyler Technologies
TYL
$13.4B
| $100K | ﹤0.01% |
1,140
+552
| +94% | +$49.8K |
|
|
BSIN
5197
Big Sky Industrial
BSIN
$73M
| $100K | ﹤0.01% |
557
-85
| -13% | -$20.2K |
|
|
BRSS
5198
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $100K | ﹤0.01% |
7,082
+6,623
| +1,443% | +$103K |
|
|
ALJ
5199
DELISTED
Alon USA Energy Inc
ALJ
| $100K | ﹤0.01% |
7,107
-480
| -6% | -$6.95K |
|
5200
PUT
Ambev
ABEV
$42.7B
| $99K | ﹤0.01% |
16,500
| – | – |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.5% of assets, up from 5% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.